Biorelevant Dissolution Testing: Methodologies & Application in Drug Development

  • Real Time Online Delivery – Live Training Sessions
  • Virtual Attendance for 5 Days Training 
  • Guided Learning Hours – 15 (3 Hrs x 5 Days)
  • Case Studies, Practical Exercises, Q & A, 
  • Pre-Course Access: Intro Session Coupon, Pre-Event Questionnaire, Presentation Slide Deck
  • 7+ Delegates Registration Group Discount

Course Overview

Dissolution testing can play an important role in several areas for drug products as a quality

control tool to monitor batch-to-batch consistency of drug release from a dosage form and as an in vitro surrogate for in vivo performance that can guide formulation development and ascertain the need for bioequivalence (BE) testing. The possibility of substituting dissolution tests for clinical studies has been revealed by the development of the Biopharmaceutics Classification System (BCS), and dissolution tests that can predict the in vivo performance of drug products could serve this purpose.

This 5 Day Online Course will highlight the current challenges in drug development and will focus on some of the main parameters that should be taken into consideration when thinking on dissolution testing towards formulation development, especially in an era where the majority of drugs in development are poorly soluble.

These daily 3 Hrs sessions will highlight, discuss & find solution to some of the most useful practices and procedures that might contribute to better planning, designing, and development of numerous products based on dissolution testing towards a successful submission and approval within the planned costs and time.

Trainer’s Profile

Our Exert Trainer has more than 20+ years of experience in academic research & the pharmaceutical industry, leading broad spectrum of drug development activities & biotech projects overseeing in all stages. 

A Phd degree from Sackler Faculty of Medicine, Tel-Aviv University and an MBA degree from The Open University of Israel. Our Expert (co)authored over 40 publications, book chapters, and inventor of 8 patents in the field of neurodegenerative diseases and fixed-dose combinations. 

Over the years held various portfolios; Clinical Regulatory Scientific Advisor, Consultant – Medical Device Product Development, Head of Specialty Products, Global Clinical Program Leader, Senior Scientist, Investigator & Coordinator in Clinical Trials 

Our Expert has provided numerous Public & In-House Lectures, Workshops, and Seminars in recent past.

Key Takeaways

  • Challenges and opportunities in drug development
  • Attainment of effective tools for measuring biorelevant dissolution in pre-clinical and clinical studies
  • Internalize the importance of quality by design (QbD) and dissolution
  • Strategic planning in clinical development towards efficient planning
  • The importance of the IVIVC & IVIVR tool in drug development
  • Grasp the options for dissolution models, methods, parameters and media
  • Understand the regulatory requirements for biorelevant dissolution testing

Who Should Attend

  • CPMs
  • CTMs
  • Pre-Clinical directors
  • Clinical directors
  • Regulatory affairs (RA) delegates
  • QA mangers
  • Chemistry Manufacturing and Controls (CMC) representatives
  • Analytical representatives
  • Project Managers
  • Any executives that would like to expand their knowledge in biorelevant dissolution testing


For participation details contact

Samuel Isaac

+1 786 633 1223(Canada)

Fill the details below to request your Brochure


    Sep 07 - 11, 2020


    <br>15:00 - 18:00 (Central European Time – CET )
    3:00 pm - 6:00 pm